Hemangioblastoma Patient Outcomes After Radiosurgery, 1993-2023

A multi-center study retrospectively analyzed data from 91 patients with large hemangioblastomas treated between 1993 and 2023. The dataset includes patient stratification into VHL-associated and sporadic groups, with assessments of radiosurgical parameters, tumor response, overall survival, and progression-free survival. The data was authored by Pavel S. Pichardo-Rojas and is available under a CC-BY-4.0 license.

Use Cases

• Compare patient survival outcomes based on VHL-associated versus sporadic tumor status.
• Analyze tumor control rates following stereotactic radiosurgery for lesions larger than 2cc.
• Investigate correlations between tumor location (e.g., cerebellar, brainstem) and treatment outcomes.
• Model progression-free survival based on patient age at diagnosis and tumor volume.

Strengths

• Data covers a 30-year time range from 1993 to 2023.
• Includes 91 patient records with detailed clinical stratification.
• Provides specific median values for age, tumor volume, and survival months.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

Pavel S. Pichardo-Rojas

Collection Method

Retrospective multi-center study.

Time Range

1993-2023

Freshness

Last updated 2026-04-17 17:40:19; freshness should be verified.

Geography

Multi-center; specific locations not stated.